Back to SKYE

BAKER BROS. ADVISORS LP → SKYE

BAKER BROS. ADVISORS LP SKYE Position History

Skye Bioscience, Inc. • Healthcare

Quarters held
4
Latest value
$317K
Q3 2026
Peak value
$1.1M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$1.1M
Q1 2026$968K
Q2 2026$1.1M
Q3 2026$317K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$317K196.9K——
Q2 2026$1.1M1.58M——
Q1 2026$968K1.58M——
Q4 2025$1.1M1.45M——

Other funds holding SKYE

Other BAKER BROS. ADVISORS LP positions

INCY

Incyte Corporation

$3.7B
INCY

Incyte Corporation

$3.5B
BEIGF

BeOne Medicines Ltd.

$3.2B
INCY

Incyte Corporation

$3B
INCY

Incyte Corporation

$2.9B
BEIGF

BeOne Medicines Ltd.

$2.7B
BEIGF

BeOne Medicines Ltd.

$2.6B
BEIGF

BeOne Medicines Ltd.

$2.5B